The ICG R15 cutoff value of 10% was first proposed by Makuuchi et al and has been commonly used in clinical practice as a reference value for right hepatectomy and larger surgeries in patients with bilirubin ≤ 17.1 μmol/L.7 In our study, we found that an ICG R15 value of 10% could also be used as a threshold for evaluating the liver function of patients receiving TACE treatments and was consistent with the Child‐Pugh score, ascites, levels of AST, ALB, TBIL, and other indicators of liver function. This evidence concerns the gene ALB and Ascites.